Biotech can — and must — reshape the pricing debate and protect future innovation
ADOBE
Make the "New Commitment" a reality to restore public trust in biotech and pharma and prevent knee-jerk policies that could limit access to medicines.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario